A comprehensive understanding of the CARD9-dependent signaling pathways and their relevance for disease processes will be required to (1) utilize CARD9 as a future therapeutic target and (2) prevent and treat possible side-effects of immune-based therapies for cancer and autoimmunity. Here, CARD9 is linked to Autoimmunity.